Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Enoxaparin (40mg) Injection
Therapeutic Category
Anticoagulant, Cardiovascular, Cardiology
Dosage Form
Injection
Packaging Type
Vial + W.F.I. + Tray
Packaging
40mg
Price
₹478/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ebonoxa 40 Injection contains Enoxaparin (40mg), a low-molecular-weight heparin (LMWH) used primarily as an anticoagulant to prevent and treat thromboembolic disorders. It works by inhibiting specific clotting factors in the blood, thereby reducing the risk of harmful blood clots. Ebonoxa is commonly prescribed to prevent deep vein thrombosis (DVT), pulmonary embolism (PE), or to manage conditions such as unstable angina and non-ST elevation myocardial infarction (NSTEMI). It may also be used for patients undergoing surgery, particularly orthopedic or abdominal surgery, to prevent clot formation during recovery.
The injection provides rapid, effective anticoagulation, and it is often preferred over unfractionated heparin due to its more predictable dosing and lower risk of bleeding complications. Administered subcutaneously, it is crucial to follow the recommended dosage and administration instructions from a healthcare provider to ensure optimal results and minimize risks.
Possible side effects include bleeding complications, bruising, elevated liver enzymes, and low platelet count (thrombocytopenia).
Prevention and treatment of thromboembolic disorders such as DVT, PE, and to manage unstable angina.
For subcutaneous use only. Follow healthcare provider instructions carefully.
Store in a cool, dry place, away from direct light. Do not freeze. Keep out of reach of children.
Composition : Enoxaparin (60mg) Injection
Composition : Heparin (5000IU) + Benzyl Alcohol (0.95%) Injection
Composition : Labetalol (5mg/1ml)
Composition : Tranexamic Acid (500mg) Injection
Composition : Tranexamic Acid (500mg)
Composition : Tranexamic Acid (250mg) + Ethamsylate (250mg)
Composition : Tranexamic Acid (250mg) + Glutathione (50mg)
Composition : Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Composition : S-adenosyl-L Methionine (400 mg)
Composition : Myo Inositol 1000 mg + L-Methylfolate 100 mcg + Vitamin D3 1000 IU
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Enoxaparin 40mg Injection is a widely used anticoagulant (blood thinner), making it a high-demand hospital product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong hospital-based demand in DVT (deep vein thrombosis), pulmonary embolism, post-surgical clot prevention, cardiac care, ICU management, and immobilized patient care. It is commonly used in emergency and critical care settings.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Enoxaparin 40mg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from consistent hospital demand, critical-care usage, repeat institutional orders, and strong acceptance in cardiology, orthopedics, and emergency medicine when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anticoagulant formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.